BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9576621)

  • 1. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis.
    Kjellén P; Issazadeh S; Olsson T; Holmdahl R
    Int Immunol; 1998 Mar; 10(3):333-40. PubMed ID: 9576621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
    Lorentzen JC; Andersson M; Issazadeh S; Dahlman I; Luthman H; Weissert R; Olsson T
    J Neuroimmunol; 1997 Dec; 80(1-2):31-7. PubMed ID: 9413257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta.
    Issazadeh S; Lorentzen JC; Mustafa MI; Höjeberg B; Müssener A; Olsson T
    J Neuroimmunol; 1996 Sep; 69(1-2):103-15. PubMed ID: 8823381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.
    Lenz DC; Wolf NA; Swanborg RH
    J Immunol; 1999 Aug; 163(4):1763-8. PubMed ID: 10438907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
    Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
    Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.
    Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J
    Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
    Lorentzen JC; Issazadeh S; Storch M; Mustafa MI; Lassman H; Linington C; Klareskog L; Olsson T
    J Neuroimmunol; 1995 Dec; 63(2):193-205. PubMed ID: 8550817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
    Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
    J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
    Maron R; Hancock WW; Slavin A; Hattori M; Kuchroo V; Weiner HL
    Int Immunol; 1999 Sep; 11(9):1573-80. PubMed ID: 10464178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.
    Di Marco R; Khademi M; Wallstrom E; Iacobaeus E; Salvaggio A; Caracappa S; Papoian R; Nicoletti F; Olsson T
    J Neuroimmunol; 2001 Jun; 116(2):168-77. PubMed ID: 11438171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
    Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
    Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
    Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
    Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
    Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
    J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
    Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
    J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.